9 completed, 1 unknown. 10 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Completed 9, Unknown 1 |
Follow Multiple Endocrine Neoplasia: new trials by email Literature Review of Multiple Endocrine Neoplasia trials Research Report on Multiple Endocrine Neoplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment Alpelisib, Fulvestrant - Advanced Breast Cancer | Phase 4 | Completed | Novartis Pharmaceuticals | 40 | 2022-08-09 | 2026-07-09 |
| GRK4 Polymorphisms Blood Pressure Response to Candesartan Candesartan - Essential Hypertension | Phase 4 | Unknown | Third Military Medical University | 500 | 2013-07-01 | 2014-11-18 |
| Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old growth hormone - Healthy | Phase 4 | Completed | Universidade Federal do Rio de Janeiro | 13 | 2012-01-01 | 2014-09-03 |
| How Much Vitamin D is Required to be Protective Against Deficiency During the Winter Months? Vitamin D, placebo - Vitamin D Deficiency | Phase 4 | Completed | McGill University | 77 | 2011-10-01 | 2014-09-05 |
| Effects of Diet-induced Weight Loss in Obese Men Optifast, Conventional diet counseling - Sexual Dysfunction, Endothelial Dysfunction | Phase 4 | Completed | Changi General Hospital | 70 | 2010-12-01 | 2015-07-29 |
| Comparing Effects of Diet, With or Without Exercise, on Sexual, Urinary and Endothelial Function, Inflammatory Profile and Quality of Life in Obese Men weight loss counselling - Sexual Dysfunction, Endothelial Dysfunction | Phase 4 | Completed | Changi General Hospital | 90 | 2010-07-01 | 2015-07-29 |
| Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men Exercise and diet - Sexual Dysfunction, Endothelial Dysfunction | Phase 4 | Completed | Changi General Hospital | 70 | 2010-07-01 | 2015-07-29 |
| Comparison of Two Antimicrobial Therapy Duration for Spondylodiscitis antibiotic - Vertebral Osteomyelitis | Phase 4 | Completed | Assistance Publique - Hôpitaux de Paris | 351 | 2006-11-01 | 2013-05-06 |
| Treatment of Zollinger-Ellison Syndrome With Prevacid Lansoprazole (Prevacid) - Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasia | Phase 4 | Completed | Charles Mel Wilcox, MD | 72 | 2003-03-01 | 2012-10-30 |
| The Role of 5-alpha Reductase in Mediating Testosterone Actions Testosterone Enanthate, Dutasteride - Healthy | Phase 4 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 184 | 2002-11-01 | 2010-05-13 |
Multiple Endocrine Neoplasia Type 1 (9) · Inflammation (4) · Obesity (3) · Sexual Dysfunction, Physiological (3) · Discitis (1) · Essential Hypertension (1) · Vitamin D Deficiency (1) · Zollinger-Ellison Syndrome (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10) · Endocrine Gland Neoplasms (10) · Endocrine System Diseases (10) · Genetic Diseases, Inborn (10) · Neoplasms (10) · Neoplasms by Site (10) · Neoplasms, Multiple Primary (10) · Neoplastic Syndromes, Hereditary (10) · Nutrition Disorders (4) · Nutritional and Metabolic Diseases (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Body Weight (3) · Genital Diseases (3)
Alpelisib (1) · Anti-Bacterial Agents (1) · Diet (1) · Dutasteride (1) · Exercise (1) · Fulvestrant (1) · Growth Hormone (1) · Lansoprazole (1) · Nutrition Assessment (1) · Vitamin D (1) · candesartan (1) · testosterone enanthate (1)
Changi General Hospital (3) · Assistance Publique - Hôpitaux de Paris (1) · Charles Mel Wilcox, MD (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · McGill University (1) · Novartis Pharmaceuticals (1) · Third Military Medical University (1) · Universidade Federal do Rio de Janeiro (1)
Singapore (3) · Brazil (1) · Canada (1) · China (1) · France (1) · India (1) · United States (1)
C. Mel Wilcox, M.D. (1) · Hope A Weiler, PhD, RD (1) · Joan J Khoo, MRCP (1) · Joan Khoo, MBBS,MRCP (1) · Joan Khoo, MRCP (1) · Louis Bernard, PU-PH (1) · Shalender Bhasin, MD (1) · Zeng Chunyu, Doctor (1)
PMID 15645403, PMID 17767471, PMID 18507843, PMID 19581810, PMID 21073392, PMID 21193359, PMID 22396515, PMID 23635309, PMID 24382963, PMID 25468170, PMID 25984880, PMID 26201019, PMID 26438497, PMID 26871769, PMID 29280355
R01HD043348 (1)